Souhaitez-vous accéder aux communiqués récents ?

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review PARIS, France, September 12, 2025, 5:45 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq –...

Baltimore, MD, Sept. 08, 2025 (GLOBE NEWSWIRE) -- A released presentation from bestselling author and entrepreneur James Altucher has revealed stunning details about Elon Musk’s most ambitious...

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Horizon...

Washington, D.C., Aug. 30, 2025 (GLOBE NEWSWIRE) -- President Trump wasted no time in signaling America’s AI priorities. “As soon as he revoked Biden’s AI order… Trump also announced the LARGEST AI...

Naples, FL, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTCID: SONG) (the “Company”), a diversified music rights and royalty holding company, today announced that it has officially...

Celebration, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, announced today that it has received formal...

San Antonio, TX, Aug. 08, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm[1] with expertise in gold mining stocks and the...

PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007 PTG-007, an autologous cell therapy will be administered to 150 high-risk children aged 3–18,...

NAPLES, FL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, announced today that it has officially submitted its application for qualification...

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial FDA agreed that PolTREG’s clinical data in Stage 3...